Vivus Inc (VVUS) SEC Filing 8-K Material Event for the period ending Monday, September 30, 2019

Vivus Inc

CIK: 881524 Ticker: VVUS

View differences made from one to another to evaluate Vivus Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Vivus Inc.


Assess how Vivus Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Vivus Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Material Contracts, Statements, Certifications & more

Vivus Inc provided additional information to their SEC Filing as exhibits

Ticker: VVUS
CIK: 881524
Form Type: 8-K Corporate News
Accession Number: 0001104659-19-052859
Submitted to the SEC: Thu Oct 03 2019 7:36:02 AM EST
Accepted by the SEC: Thu Oct 03 2019
Period: Monday, September 30, 2019
Industry: Pharmaceutical Preparations
  1. Event for Officers
  2. Financial Exhibit
  3. New Agreement
  4. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: